The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Canadian Banks: It’s Nice to Be First
Alexander Wissel, Editor in Chief, Investment U
More often then you would imagine, the editors at Investment U see echoes, reflections and sometimes, downright copies, of the ideas we publish on a daily basis. Most of the time it’s flattering.
It’s a sign that we’re supporting something the Wall Street establishment recognizes as valuable. And while its not always easy – or popular – to endorse ideas that are outside conventional thinking. We take pride in knowing that we are on the front edge of the “learning” curve.
In fact, last Thursday we published an article on the strength of the Canadian banking system from Panelist Mark Skousen. He showed readers how one of the world’s soundest banking systems is right next door.
Just two days later, in The New York Times, they published “The Great Solvent North,” an article by op-ed contributor Theresa Tedesco espousing the exact same point of view. She has done a nice job of expanding Mark’s article and fleshing a few of the more political aspects of domestic banking policy.
Now it’s clear that this isn’t a plagiarism issue, but rather a continuation of the ideas that we brought to life at Investment U. And ultimately, a good idea is a good idea, regardless of where it comes from, or how many people promote it.
It’s nice to be first though…
To read Mark Skousen’s full article, go here. To read the follow up story from The New York Times, go here.
Kudos, Mark.
- Commercial Real Estate Crisis: It’s nice to be first
- Canadian Banks: An Oasis of Financial Calm
- Canadian Banking: Sober, Boring, and Successful
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed